ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK

Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

30 May 2024 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors

29 May 2024 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting

23 May 2024 16:01:39 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit

14 May 2024 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress

07 May 2024 06:00:01 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 May 2024 16:30:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024

02 Apr 2024 15:05:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Apr 2024 16:30:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Mar 2024 17:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

28 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates

27 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference

13 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Feb 2024 16:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

25 Jan 2024 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Jan 2024 15:49:03 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Dec 2023 16:39:15 By Nasdaq GlobeNewswire

Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD Cowen

09 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates

06 Nov 2023 06:18:31 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Nov 2023 15:52:14 By Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Oct 2023 15:27:36 By Nasdaq GlobeNewswire